IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101. A total of 14 filers reported holding IMMUNE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,000 | -28.6% | 25,000 | 0.0% | 0.00% | -57.1% |
| Q3 2016 | $7,000 | -30.0% | 25,000 | 0.0% | 0.01% | -46.2% |
| Q2 2016 | $10,000 | -9.1% | 25,000 | 0.0% | 0.01% | -13.3% |
| Q1 2016 | $11,000 | -57.7% | 25,000 | -28.6% | 0.02% | -6.2% |
| Q4 2015 | $26,000 | -36.6% | 35,000 | 0.0% | 0.02% | -57.9% |
| Q3 2015 | $41,000 | -39.7% | 35,000 | 0.0% | 0.04% | -9.5% |
| Q2 2015 | $68,000 | +7.9% | 35,000 | 0.0% | 0.04% | 0.0% |
| Q1 2015 | $63,000 | -4.5% | 35,000 | 0.0% | 0.04% | +16.7% |
| Q4 2014 | $66,000 | -50.7% | 35,000 | -12.5% | 0.04% | -62.1% |
| Q3 2014 | $134,000 | – | 40,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | 158,998 | $29,000 | 0.01% |
| Geduld E E | 25,000 | $5,000 | 0.00% |
| UBS Group AG | 100,064 | $18,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 27,500 | $5,000 | 0.00% |
| Advisor Group, Inc. | 75,000 | $14,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 447,068 | $81,000 | 0.00% |
| DEUTSCHE BANK AG\ | 28 | $0 | 0.00% |
| GOLDMAN SACHS GROUP INC | 36,225 | $7,000 | 0.00% |
| VANGUARD GROUP INC | 3,981,879 | $725,000 | 0.00% |
| BlackRock Fund Advisors | 8,931 | $2,000 | 0.00% |